North America dominated the CBD oil market with the largest revenue share of 42.5% in 2024, driven by early legalization of hemp-derived CBD, high consumer awareness, and a robust presence of key industry players. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. The rise of e-commerce and online pharmacies has made Balance Bloom CBD Gummies oil more accessible, catering to a growing consumer base seeking personalized health and wellness solutions. These factors may limit market growth in cost-sensitive regions or areas with high regulatory scrutiny, such as parts of Asia-Pacific and the Middle East. The market is segmented on the basis of source type, extract type, extraction method, distribution channel, and end use.

On the basis of source type, the global cannabidiol (CBD) oil extract market is segmented into hemp and marijuana. The hemp segment dominated the largest market revenue share of 56.8% in 2024, driven by its legal status in many regions, including the U.S., Canada, and parts of Europe, where hemp-derived CBD with less than 0.3% THC is widely permitted. This regulatory clarity facilitates broader production and distribution. The marijuana segment is expected to witness the fastest growth rate of 19.5% from 2025 to 2032, fueled by increasing legalization of marijuana-based CBD products for medical and therapeutic applications, particularly in regions with progressive cannabis regulations. The higher CBD concentration in marijuana allows for more potent formulations. On the basis of extract type, the global cannabidiol (CBD) oil extract market is segmented into full spectrum extracts and cannabis isolates. The full spectrum extracts segment is expected to hold the largest market revenue share of 70.7% in 2024, attributed to its entourage effect, where the synergistic interaction of cannabinoids and terpenes enhances therapeutic benefits, appealing to consumers seeking holistic wellness solutions.

The cannabis isolates segment is anticipated to experience the fastest growth rate of 21.0% from 2025 to 2032, driven by demand for pure CBD products free of THC and other cannabinoids. This purity is preferred for precise dosing and by consumers with sensitivities or those requiring high-potency medical applications. On the basis of extraction method, the global cannabidiol (CBD) oil extract market is segmented into solvent based and non-solvent based. The solvent based segment is expected to hold the largest market revenue share of 60.2% in 2024, owing to its efficiency, cost-effectiveness, and FDA-approved solvents, making it a preferred method for producing CBD extracts for pharmaceuticals, personal care, and food industries. The non-solvent based segment is projected to witness significant growth from 2025 to 2032, driven by consumer preference for cleaner, more natural extraction methods such as CO2 extraction, which ensures higher purity and bioavailability without residual solvents. Advancements in technology further support its adoption.

On the basis of distribution channel, the global cannabidiol (CBD) oil extract market is segmented into B2B and B2C. The B2B segment dominated the market with a revenue share of 56.0% in 2024, driven by bulk purchasing by pharmaceutical, wellness, and food and beverage companies for manufacturing CBD-infused products. The growing number of wholesalers and expanding consumer base further bolster this segment. The B2C segment is expected to witness the fastest growth rate of 20.5% from 2025 to 2032, fueled by increasing consumer awareness of CBD’s health benefits and the rise of e-commerce platforms, retail pharmacies, and online stores offering diverse CBD products such as oils, edibles, and topicals. On the basis of end use, the global cannabidiol (CBD) oil extract market is segmented into medical, personal use, pharmaceutical, and wellness. The pharmaceutical segment held the largest market revenue share of 38.2% in 2024, driven by CBD’s therapeutic applications in treating conditions such as epilepsy, chronic pain, and anxiety, supported by regulatory approvals such as Epidiolex for seizure treatment.

The wellness segment is anticipated to experience rapid growth of 22.3% from 2025 to 2032, fueled by rising consumer demand for CBD-infused products in cosmetics, nutraceuticals, and food and beverages, driven by trends toward natural and plant-based health solutions. Consumers prioritize CBD oil for its potential therapeutic benefits, including pain relief, anxiety reduction, and improved sleep quality, particularly in regions with high health and wellness awareness. Growth is supported by advancements in extraction technologies, such as solvent-based and non-solvent-based methods, alongside increasing adoption in both B2B and B2C distribution channels across medical, pharmaceutical, and personal use segments. The U.S. cannabidiol (CBD) oil market captured the largest revenue share of 78.8% in 2024 within North America, fueled by robust consumer awareness of CBD’s health benefits and a strong B2C market for wellness products. The trend towards natural health remedies and favorable regulations for hemp-derived CBD products drive market expansion. The integration of Balance Bloom CBD Gummies oil in pharmaceuticals and personal care products, combined with a thriving e-commerce ecosystem, supports sustained growth.